The Evo team (Arc Institute)
November 14, 2024 02:00 PM ESTUpdated 03:04 PM
AI
Cell/Gene Tx

Arc In­sti­tute pub­lish­es new AI mod­el Evo, cre­at­ing CRISPR sys­tems in a leap for syn­thet­ic bi­ol­o­gy

Andrew Dunn

Senior Biopharma Correspondent

Less than a decade ago, a slew of star­tups like Metageno­mi and Mam­moth Bio­sciences raised huge sums of mon­ey …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA says Ozem­pic, We­govy short­age is over

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

Kevin Tang's Con­cen­tra tries to dis­rupt pro­posed Ace­lyrin-Alu­mis merg­er

Pfiz­er ends roll­out of Be­qvez, putting an­oth­er dent in he­mo­phil­ia gene ther­a­py field

Mer­ck KGaA tees up changes to lead­er­ship team; Ex-CVS Health CEO joins Ther­mo Fish­er’s board

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times